Why Illumina Stock Is Sinking Today | The Motley Fool
The genomic-sequencing company's CFO is unexpectedly leaving for another company.
Stay updated with breaking news from Sam Samad. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The genomic-sequencing company's CFO is unexpectedly leaving for another company.
These are the stocks posting the largest moves before the bell.
/PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that Sam Samad will become...
/PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced Joydeep Goswami, Chief Strategy...
WASHINGTON (dpa-AFX) - Quest Diagnostics (DGX) Thursday said it has appointed Sam Samad as new Chief Financial Officer. Samad succeeds Mark Guinan, who in February had announced his decision to